RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the cultivation and sale of Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. The company offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot, TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot, and Collagen Max Drink, a liquid form dietary supplement; and Barbie… Read more
RAJAF (RAJAF) - Total Liabilities
Latest total liabilities as of December 2023: $3.50 Million USD
Based on the latest financial reports, RAJAF (RAJAF) has total liabilities worth $3.50 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
RAJAF - Total Liabilities Trend (2020–2024)
This chart illustrates how RAJAF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
RAJAF Competitors by Total Liabilities
The table below lists competitors of RAJAF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
|
China | $12.41 Billion |
|
Ricardo plc
F:RIR
|
Germany | €273.90 Million |
|
Tropicana Corporation Bhd
KLSE:5401
|
Malaysia | RM6.19 Billion |
|
Smart Eye AB
ST:SEYE
|
Sweden | Skr604.67 Million |
|
CviLux Corp
TW:8103
|
Taiwan | NT$2.06 Billion |
|
Adimmune Corp
TW:4142
|
Taiwan | NT$3.53 Billion |
|
Lotus Resources Ltd
AU:LOT
|
Australia | AU$43.91 Million |
|
Klaveness Combination Carriers ASA
OL:KCC
|
Norway | Nkr299.29 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down RAJAF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -23.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RAJAF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RAJAF (2020–2024)
The table below shows the annual total liabilities of RAJAF from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.00 Million | +42.69% |
| 2023-12-31 | $3.50 Million | +14.64% |
| 2022-12-31 | $3.06 Million | -13.64% |
| 2021-12-31 | $3.54 Million | +24.67% |
| 2020-12-31 | $2.84 Million | -- |